Close Menu

The story has been amended to update the number of bacterial, fungal, and viral respiratory pathogens detected by IDbyDNA's technology.

NEW YORK (GenomeWeb) – IDbyDNA announced today that it has signed a licensing agreement with Brazil-based Fleury Group to offer IDbyDNA's Explify platform for clinical metagenomic testing in South America.  

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.